Progress Adult Study

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2011 by The HIV Netherlands Australia Thailand Research Collaboration
Sponsor:
Collaborators:
Bamrasnaradura Institute
Sanpatong Hospital
Information provided by:
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01328275
First received: March 2, 2011
Last updated: April 1, 2011
Last verified: April 2011

March 2, 2011
April 1, 2011
December 2007
September 2015   (final data collection date for primary outcome measure)
HIV related adverse events [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
Time until patient has HIV related adverse events
Same as current
Complete list of historical versions of study NCT01328275 on ClinicalTrials.gov Archive Site
  • Immunological failure [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    time to immunological failure
  • virological failure [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    time to virological failure
  • the change of quality of life [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    time to change of quality of life
  • depression [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    time when patient develops depression
  • genotypic resistance [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    time to developing genotypic resistance
Same as current
Not Provided
Not Provided
 
Progress Adult Study
The Thai HIV Disease Progression: An Observational Database

The purpose of this study is to study the HIV disease progression in HIV-infected Thai Adult.

This is a multicenter, observational prospective cohort study. All HIV-infected patients from Bamrasnaradura Institute, Sanpatong Hospital and HIV-NAT, Thai Red Cross AIDS Research Centre, are followed to assess HIV disease progression.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

serum

Probability Sample

HIV-infected patients currently receiving ART at Bamrasnaradura Institute, Sanpatong Hospital or HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok.

  • Acquired Immunodeficiency Syndrome
  • Depression
Drug: standard regimens according to the Thai Ministry of Public Health national guidelines
Participants may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.
1
long-term follow-up of HIV-infected patients on ART
Intervention: Drug: standard regimens according to the Thai Ministry of Public Health national guidelines
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
5600
September 2015
September 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. There is evidence that HIV infection true (blood positive results by ELISA (ELISA) has been confirmed or detected evidence co-infection. HIV in the body by PCR, HIV-RNA PCR).Currently on PI regimens
  2. Signed consent form
  3. Age> 18 years

Exclusion Criteria:

  1. Patients who came for treatment in a department other than out patient, such as inpatient or emergency room.
  2. Patients are not willing to receive treatment on a regular basis in all 3 hospitals as patients normally receive treatment at other hospitals on a regular basis. However, due to urgent events. Need to receive treatment in hospital and three of.
  3. Patients who have been diagnosed by doctors as a Psychological disorder that can not store the data.
  4. Patients who have been diagnosed by a medical condition that Alcoholism
Both
18 Years and older
No
Contact: Wisit Prasithsirikul, MD 6625903408 drwisit_p@yahoo.com
Contact: Jintanat Ananworanich, MD, PHD 662-652-3040 ext 280 jintanat.a@hivnat.org
Thailand
 
NCT01328275
HIV-NAT 153
No
Wisit Prasithsirikul, Bamrasnaradura Infectious Disease Institute
The HIV Netherlands Australia Thailand Research Collaboration
  • Bamrasnaradura Institute
  • Sanpatong Hospital
Principal Investigator: Wisit Prasithsirikul, MD Bamrasnaradura infectious disease institute
Principal Investigator: Wirat Klinbuayam, MD Sanpatong Hospital
Principal Investigator: Jintanat Ananworanich, MD, PhD HIV-NAT, Thai Red Cross AIDS Research Centre
The HIV Netherlands Australia Thailand Research Collaboration
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP